Vergent Bioscience to Present New Efficacy Results from Phase 2 Clinical Trial of VGT-309 at Annual Meeting of The Society of Thoracic Surgeons
STS 2024 session will highlight potential of tumor-targeted fluorescent imaging agent to enhance minimally invasive surgery by improving the visualization of cancer... Read more.
Stova Appoints Event Technology Industry Veteran as New CEO to Drive Next Phase of Growth
Kirk Ziehm joins as CEO to drive Stova’s industry-leading event technology solutions NEW YORK–(BUSINESS WIRE)–Stova, a leading event management technology... Read more.
Godspeed Capital Sells MOREgroup
WASHINGTON–(BUSINESS WIRE)–Godspeed Capital Management LP (“Godspeed Capital”), a lower middle-market Defense & Government services, solutions,... Read more.
HOOPS Communicator 2024 Provides Full Support of 3D Connexion, Improves Color and Light Editing Workflows
Enhancements to the leading toolkit for 3D web visualization provide important capabilities for editing workflows BEND, Ore.–(BUSINESS WIRE)–Tech Soft... Read more.
Allosteric Bioscience, Inc. Signs Sponsored Research Agreement with Dr. Susan Michaelis at Johns Hopkins University for Aging/Longevity-Related Work
NEW YORK–(BUSINESS WIRE)–Allosteric Bioscience, Inc. (ABI) has signed a Sponsored Research Agreement (SRA) with Dr. Susan Michaelis at Johns Hopkins... Read more.
Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market
BOSTON–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that... Read more.
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
BOSTON–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased... Read more.
Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence
COSMOS study shows Guardant Reveal™ blood test highly predictive for disease recurrence in patients with early-stage colon cancer without need for tissue specimen... Read more.
Clear Street Introduces Corporate Access Capabilities
New service focuses on transparency, execution excellence, and full life cycle support for investors and corporates NEW YORK–(BUSINESS WIRE)–Clear Street... Read more.
Geneoscopy Forms Scientific Advisory Board to Support Advancement of Precision Immunology Diagnostics for Inflammatory Bowel Disease (IBD)
ST. LOUIS–(BUSINESS WIRE)–Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health,... Read more.